AKUS Market Cap History
Below is a table of the AKUS market cap history going back to 6/26/2020:

Date AKUS Market Cap

Also see: AKUS Shares Outstanding History
and AKUS YTD Return
AKUS Historical Market Cap:
-54.67% CAGR
AKUS Historical Market Cap: +-54.67% CAGR

Mouse over chart for data details
Akouos is a genetic medicine company, engaged in developing gene therapies to restore, improve, and preserve physiologic hearing for individuals who live with disabling hearing loss. Co. has a genetic medicine platform that incorporates a proprietary vector library consisting of variants of a small virus used in gene therapy, known as adeno-associated virus, and a delivery approach. Co. is developing its product candidate, AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene; expansion of its pipeline to include programs focused on other monogenic conditions as well as inner ear conditions of etiology, such as AK-antiVEGF for vestibular schwannoma. We show 10 historical shares outstanding datapoints in our AKUS shares outstanding history coverage, used to compute AKUS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AKUS market cap history over the course of time is important for investors interested in comparing AKUS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AKUS versus a peer is one thing; comparing AKUS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AKUS can fluctuate over the course of history. With this page we aim to empower investors researching AKUS by allowing them to research the AKUS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AKUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akouos (AKUS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AKYA Market Cap History
ALBO Market Cap History
ALBT Market Cap History
ALC Market Cap History
ALDR Market Cap History
ALDX Market Cap History
ALEC Market Cap History
ALGN Market Cap History
ALGS Market Cap History
ALHC Market Cap History
More Healthcare companies »


AKUS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.